Layanson Pharma Ltd
Registered name: LAYANSON PHARMA LTD
Layanson Pharma Ltd made £1.3m revenue and a £71.6k loss in the year to 28 Feb 2025.
Layanson Pharma Ltd’s revenue grew 85% to £1.3m in the year to 28 Feb 2025, with a loss of £71.6k and 19 employees. The company is classified under “wholesale of pharmaceutical goods” and is based in Thornbury; we hold 2 years of its filed accounts.
- Status
- Active
- Location
- Thornbury, South West
- Age
- 3 yrs · since 2023
- Type
- Private Limited Company
Key figures
Badges are automated estimates derived from the filed figures — not statements of fact about the company.
Financial history
| Year to | 29 Feb 2024 | 28 Feb 2025 |
|---|---|---|
| Disclosure | Full P&L | Full P&L |
| Profit & loss | ||
| Revenue (turnover) | £687k | £1.3m |
| Cost of sales | £401k | £846k |
| Gross profit | £285k | £424k |
| Operating profit | £97.9k | £45.4k |
| Profit before tax | £97.6k | £542 |
| Profit after tax | £58.4k | −£71.6k |
| Profit (best available) | £58.4k | −£71.6k |
| Employees (average) | 10 | 19 |
| Ratios | ||
| Profit margin | 8.5% | −5.6% |
| Gross margin | 41.5% | 33.4% |
| Revenue per employee | £68.7k | £66.8k |
| Profit per employee | £5.8k | −£3.8k |
| Growth (year on year) | ||
| Revenue growth | — | ▲85% |
| Profit growth | — | ▼222.7% |
| Headcount growth | — | ▲90% |
| Balance sheet — indirect signals, not revenue | ||
| Cash at bank | £23.3k | £90.2k |
| Net assets | £58.4k | −£21.5k |
| Fixed assets | £338k | £350k |
| Current assets | £338k | £340k |
| Debtors | £268k | £101k |
| Source | FilletedAccounts · bulk data Oct 2024 | FilletedAccounts · bulk data Oct 2025 |
How the business works
- Profit margin
- −5.6%
- Profit ÷ revenue.
- Gross margin
- 33.4%
- Gross profit ÷ revenue. High for software and services.
- Revenue per employee
- £66.8k
- Revenue ÷ average employees.
- Profit per employee
- −£3.8k
- Profit ÷ average employees.
- Cash conversion
- —
- Cash generated from operations ÷ operating profit. Needs a cash-flow statement.
- Fixed assets ÷ revenue
- 27.6%
- Capital intensity. Low = capital-light, cheaper to start.
- Deferred income ÷ revenue
- —
- Customers paying upfront (subscriptions, deposits). Approximate when combined with accruals.
- Debtors ÷ revenue
- 8%
- Money owed by customers. Low = customers pay quickly.
Balance-sheet signals
Year-on-year changes in filed balance-sheet items. They can hint at momentum (or investment) but are not revenue or profit and must not be read as such.
- Net assets
- ▼137%
- Now −£21.5k
- Cash at bank
- ▲287%
- Now £90.2k
- Headcount
- ▲90%
- Now 19
- Deferred income
- —
- Now —
- Fixed assets
- ▲4%
- Now £350k
Similar profitable businesses
- Guardant Health UK LimitedLondon · Wholesale of pharmaceutical goods
- Revenue
- £1.8m
- Profit
- £21.6k
- Staff
- 7
- Instruments and Laboratory Supplies LimitedSouthampton · Wholesale of pharmaceutical goods
- Revenue
- £626k
- Profit
- £4.3k
- Staff
- 0
- Beijing Tong Ren Tang (UK) LimitedWholesale of pharmaceutical goods
- Revenue
- £560k
- Profit
- £20.7k
- Staff
- 8
- MTK Life LtdHarrow · Wholesale of pharmaceutical goods
- Revenue
- £478k
- Profit
- £21.7k
- Staff
- 0
- Itf Pharma LtdLondon · Wholesale of pharmaceutical goods
- Revenue
- £3.6m
- Profit
- £320k
- Staff
- 9
Sources
Latest figures from FilletedAccounts for the year to 28 Feb 2025 (profit −£71.6k), from the Companies House accounts bulk data published Oct 2025. Spotted an error? Request a correction.
Contains public sector information from Companies House licensed under the Open Government Licence v3.0. Data from Companies House, © Crown copyright. View the licence.